ATE428725T1 - Neurovirulenter stamm des west-nile-virus und anwendungen davon - Google Patents

Neurovirulenter stamm des west-nile-virus und anwendungen davon

Info

Publication number
ATE428725T1
ATE428725T1 AT02759815T AT02759815T ATE428725T1 AT E428725 T1 ATE428725 T1 AT E428725T1 AT 02759815 T AT02759815 T AT 02759815T AT 02759815 T AT02759815 T AT 02759815T AT E428725 T1 ATE428725 T1 AT E428725T1
Authority
AT
Austria
Prior art keywords
applications
west nile
nile virus
neurovirulent strain
neurovirulent
Prior art date
Application number
AT02759815T
Other languages
English (en)
Inventor
Philippe Despres
Vincent Deubel
Jean-Louis Guenet
Marie-Therese Drouet
Mertyn Malkinson
Caroline Banet
Marie-Pascale Frenkiel
Marie-Pierre Courageot
Fasseli Coulibaly
Adeline Catteau
Marie Flamand
Patrick Weber
Pierre-Emmanuel Ceccaldi
Original Assignee
Pasteur Institut
Kimron Veterinary Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26212954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE428725(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0104599A external-priority patent/FR2823218B1/fr
Priority claimed from FR0111525A external-priority patent/FR2829149B1/fr
Application filed by Pasteur Institut, Kimron Veterinary Inst filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE428725T1 publication Critical patent/ATE428725T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT02759815T 2001-04-04 2002-04-04 Neurovirulenter stamm des west-nile-virus und anwendungen davon ATE428725T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0104599A FR2823218B1 (fr) 2001-04-04 2001-04-04 Souche neurovirulente du virus west nile et ses applications
FR0111525A FR2829149B1 (fr) 2001-09-06 2001-09-06 Souche neurovirulente du virus west nile et ses applications
PCT/FR2002/001168 WO2002081511A1 (fr) 2001-04-04 2002-04-04 Souche neurovirulente du virus west-nile et ses applications

Publications (1)

Publication Number Publication Date
ATE428725T1 true ATE428725T1 (de) 2009-05-15

Family

ID=26212954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02759815T ATE428725T1 (de) 2001-04-04 2002-04-04 Neurovirulenter stamm des west-nile-virus und anwendungen davon

Country Status (9)

Country Link
EP (1) EP1383796B2 (de)
AT (1) ATE428725T1 (de)
CA (1) CA2443290C (de)
CY (1) CY1109244T1 (de)
DE (1) DE60231970D1 (de)
DK (1) DK1383796T3 (de)
ES (1) ES2327217T5 (de)
PT (1) PT1383796E (de)
WO (1) WO2002081511A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003297996A1 (en) * 2002-12-12 2004-07-09 Chiron Corporation Identification of oligonucleotides for the capture, detection and quantitation of west nile virus
BRPI0408967B8 (pt) 2003-03-31 2021-07-27 Hoffmann La Roche kit e métodos para detecção de um ácido nucléico de vários membros do sorogrupo do vírus da encefalite japonesa em uma amostra biológica sob condições de hibridização rigorosas
WO2005047522A2 (en) 2003-11-12 2005-05-26 Bayer Healthcare Llc Oligonucleotides and methods for detection of west nile virus
RU2265658C2 (ru) * 2004-01-09 2005-12-10 Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") Штамм гибридных клеток животного mus musculus l. 9e2, используемый для получения моноклональных антител к белку e вируса западного нила штамм wnv/leiv-vig99-27889
FR2870126B1 (fr) 2004-05-17 2009-07-17 Pasteur Institut Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin
US8999675B2 (en) 2009-08-31 2015-04-07 Gen-Probe Incorporated Dengue virus assay
RU2595429C1 (ru) * 2015-04-21 2016-08-27 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") ШТАММ ГИБРИДНЫХ КЛЕТОК ЖИВОТНОГО Mus musculus L. 5Н6 - ПРОДУЦЕНТ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ДЛЯ ВЫЯВЛЕНИЯ ГЛИКОПРОТЕИНА Е ВИРУСА ЗАПАДНОГО НИЛА, МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА 5Н6, ПРОДУЦИРУЕМЫЕ УКАЗАННЫМ ШТАММОМ ГИБРИДНЫХ КЛЕТОК, И ИММУНОФЕРМЕНТНЫЙ НАБОР ДЛЯ ВЫЯВЛЕНИЯ ГЛИКОПРОТЕИНА Е ВИРУСА ЗАПАДНОГО НИЛА С ИСПОЛЬЗОВАНИЕМ УКАЗАННЫХ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1102605A1 (ru) * 1982-05-05 1984-07-15 Войсковая Часть 41598 Способ получени диагностического иммуноглобулина к вирусу Западного Нила

Also Published As

Publication number Publication date
EP1383796B2 (de) 2012-08-22
DK1383796T3 (da) 2009-08-17
CA2443290C (fr) 2011-11-08
ES2327217T3 (es) 2009-10-27
EP1383796B1 (de) 2009-04-15
PT1383796E (pt) 2009-07-21
CA2443290A1 (fr) 2002-10-17
ES2327217T5 (es) 2013-02-11
DE60231970D1 (de) 2009-05-28
CY1109244T1 (el) 2014-07-02
EP1383796A1 (de) 2004-01-28
WO2002081511A1 (fr) 2002-10-17

Similar Documents

Publication Publication Date Title
FR2822164B1 (fr) Polypeptides derives des arn polymerases, et leurs utilisations
WO2005056584A3 (fr) Nouvelle souche de coronavirus associe au sras et ses applications.
EP1373296A4 (de) Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung
ATE530643T1 (de) Säureaktive fungale protease
SI1685243T1 (sl) Imortalizirane ptičje celične linije za produkcijo virusov
UA92132C2 (ru) Высокоактивные рекомбинантные вирусы гриппа для вакцин и генотерапии
NO20082783L (no) Induserbare ekspresjonssystemer
NO20033240L (no) Microorganismer og fremgangsmåter for öket produksjon av pantotenat
KR100469936B1 (ko) 사스 바이러스 항원의 세포표면 발현벡터 및 상기 벡터에의해 형질전환된 미생물
ATE310089T1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
ATE399210T1 (de) Knockout-mutante von vaccinia-virus und verwendung davon
DK1390543T3 (da) Nye polynukleotider og polypeptider af IFNalfa-17-genet
EA200601043A1 (ru) Промоторы для экспрессии в модифицированном вирусе осповакцины штамма анкара
TW200508246A (en) Anti-dengue virus antibodies, compositions, methods and uses
DE60231970D1 (de) Neurovirulenter stamm des west-nile-virus und anwendungen davon
SE9801455D0 (sv) New receptor
DE60034884D1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
DE60040219D1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
DE50214936D1 (de) Verwendung des adenoviralen e2-late-promotors
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
DE60229966D1 (de) Diabetesmodell
DK1893755T3 (da) Fremgangsmåde til fremstilling af lipaser
FR2866025B1 (fr) Utilisation des proteines et des peptides codes par le genome d'une nouvelle souche de coronavirus associe au sras
DK1461437T3 (da) Ekspressionsvektorer og promotorer til heterolog genekspression
WO2004046168A3 (en) Recombinant hiv-1 subclass d envelope glycoproteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1383796

Country of ref document: EP